From: Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
Day
Variant(s)
29
A1841G; p.D614G
C2168T;p.T723I
79
150
419_427del; p.L141_V143del
G2306C; p.G769A